Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) traded at $9.77 at close of the session on Tuesday, July 15 and made an upward move of 1.35% on its previous day’s price.
Looking at the stock we see that its previous close was $9.64 and the beta (5Y monthly) reads 0.944 with the day’s price range being $7.63 – $10.38. In terms of its 52-week price range, SONN has a high of $19.30 and a low of $1.08. The company’s stock has gained about 727.97% over that past 30 days.
Sonnet BioTherapeutics Holdings Inc has a market cap of $30.93 million and is expected to release its quarterly earnings report on 2025-May-13.
On the other hand, looking at the outlook for the SONN stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 50% Buy.
Based on estimates by 2 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Sonnet BioTherapeutics Holdings Inc (SONN) stock as a Hold, while 2 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 202.66% off its SMA20 and 381.78% from its 50-day simple moving average. The RSI (14) is pointing at 93.10 while the volatility over the past week is 49.49% and jumps to 31.50% over the past one month.
Coming back to Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN), we note that the average 3-month trading volume was 3.60 million, while that of the preceding 10-day period stands at 21.72 million. Current shares outstanding are 3.17 million.
The insiders hold 1.17% of the company’s shares while institutions hold 5.09%. The data shows that short shares as of 2025-06-13, stood at 60829.0 at a short ratio of 1.57. This represents a 194.00 short interest in shares outstanding on 2025-06-13. Shares short fall in June from the previous month at 98090.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 34.20% up in year-to-date price movement.
